ベンドロフルアジド
- 関
- bendroflumethiazide
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2015/07/17 23:15:15」(JST)
[Wiki en表示]
Bendroflumethiazide
|
|
Systematic (IUPAC) name |
3-Benzyl-1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1,2,4- benzothiadiazine-7-sulfonamide
|
Clinical data |
AHFS/Drugs.com |
Consumer Drug Information |
Pregnancy
category |
- Risk neonatal thrombocytopenia in 3rd trimester[1]
|
Legal status |
- UK: Prescription-only (POM)
|
Routes of
administration |
Oral |
Pharmacokinetic data |
Bioavailability |
100% |
Protein binding |
96% |
Metabolism |
extensive |
Biological half-life |
3-4 hours[2] |
Identifiers |
CAS Registry Number |
73-48-3 Y |
ATC code |
C03AA01 |
PubChem |
CID: 2315 |
IUPHAR/BPS |
7122 |
DrugBank |
DB00436 Y |
ChemSpider |
2225 Y |
UNII |
5Q52X6ICJI Y |
KEGG |
D00650 Y |
ChEBI |
CHEBI:3013 Y |
ChEMBL |
CHEMBL1684 Y |
Chemical data |
Formula |
C15H14F3N3O4S2 |
Molecular mass |
421.415 g/mol |
SMILES
-
FC(F)(F)c3c(cc1c(NC(NS1(=O)=O)Cc2ccccc2)c3)S(=O)(=O)N
|
InChI
-
InChI=1S/C15H14F3N3O4S2/c16-15(17,18)10-7-11-13(8-12(10)26(19,22)23)27(24,25)21-14(20-11)6-9-4-2-1-3-5-9/h1-5,7-8,14,20-21H,6H2,(H2,19,22,23) Y
-
Key:HDWIHXWEUNVBIY-UHFFFAOYSA-N Y
|
Y (what is this?) (verify) |
Bendroflumethiazide (INN), formerly bendrofluazide (BAN), trade name Aprinox, is a thiazide diuretic used to treat hypertension.
Bendroflumethiazide is a thiazide diuretic which works by inhibiting sodium reabsorption at the beginning of the distal convoluted tubule (DCT). Water is lost as a result of more sodium reaching the collecting ducts. Bendroflumethiazide has a role in the treatment of mild heart failure although loop diuretics are better for reducing overload. The main use of bendroflumethiazide currently is in hypertension (part of the effect is due to vasodilation).
Contents
- 1 Adverse effects
- 1.1 Alcohol
- 1.2 Other considerations
- 2 References
Adverse effects
Common adverse effects:[3]
- postural hypotension
- hyponatraemia, hypokalaemia, hypercalcaemia
- gout
- impaired glucose tolerance
- impotence
- fatigue
- pulmonary oedema
- pneumonitis
Rare adverse effects:[4]
- thrombocytopenia
- agranulocytosis
- photosensitivity rash
- pancreatitis
- renal insufficiency
Alcohol
Bendroflumethiazide is known to have an adverse interaction with alcohol. It is advised that those using this diuretic should abstain from alcohol consumption during use, as it is possible to experience a sudden drop in blood pressure, especially if standing up.
Other considerations
Bendroflumethiazide should not be used by pregnant women, or women who have just given birth. Due to the nature of the medication, it is possible for it to pass into the breast milk and consequently to the child. It is also known that bendroflumethiazide suppresses the production of breast milk. Pregnant or lactating women with hypertension may need to discuss with their prescriber as to which alternative treatment may be more suitable. Bendroflumethiazide may also impair the user's motor skills, therefore it is important to be aware of its effects and to take caution when operating machinery of driving.[5]
References
- ^ BNF 45 March 2003
- ^ Ed. Sean C. Sweetman (ed.). Martindale: The complete drug reference (33 ed.). Pharmaceutical Press.
- ^ Bendroflumethiazide Side Effects - Common euroClinix.co.uk
- ^ Bendroflumethiazide Side Effects Drugs.com
- ^ Bendroflumethiazide (Bendroflumethiazide 2.5mg tablets) NHS.uk
Symporter inhibitors
|
|
Sodium chloride |
- thiazide: Bendroflumethiazide
- Chlorothiazide
- Cyclopenthiazide
- Cyclothiazide
- Hydrochlorothiazide
- Hydroflumethiazide
- Methyclothiazide
- Polythiazide
- Trichlormethiazide
other: Chlorthalidone
- Metolazone
|
|
Sodium, potassium, chloride |
|
|
Antihypertensives: diuretics (C03)
|
|
Sulfonamides
(and etacrynic acid) |
CA inhibitors (at PT) |
|
|
Loop (Na-K-Cl at AL) |
- Furosemide#
- Bumetanide
- Etacrynic acid
- Etozoline
- Muzolimine
- Piretanide
- Tienilic acid
- Torasemide
|
|
Thiazides (Na-Cl at DCT,
Calcium-sparing) |
- Altizide
- Bendroflumethiazide
- Chlorothiazide
- Cyclopenthiazide
- Cyclothiazide
- Epithiazide
- Hydrochlorothiazide#
- Hydroflumethiazide
- Mebutizide
- Methyclothiazide
- Polythiazide
- Trichlormethiazide
|
|
Thiazide-likes (primarily DCT) |
- Quinethazone
- Clopamide
- Chlortalidone
- Mefruside
- Clofenamide
- Metolazone
- Meticrane
- Xipamide
- Indapamide
- Clorexolone
- Fenquizone
|
|
|
Potassium-sparing (at CD) |
ESC blockers |
- Amiloride#
- Triamterene
- Benzamil
|
|
Aldosterone antagonists |
- Spironolactone#
- Eplerenone
- Potassium canrenoate
- Canrenone
|
|
|
Osmotic diuretics (PT, DL) |
|
|
Vasopressin receptor inhibitors
(DCT and CD) |
- vaptans: Conivaptan
- Mozavaptan
- Satavaptan
- Tolvaptan
- others: Demeclocycline
- Lithium carbonate
|
|
Other |
- ethanol, isopropanol, 2M2B
- mercurial diuretic (Mersalyl, Meralluride)
- Theobromine
- Cicletanine
|
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
Index of the circulatory system
|
|
Description |
- Anatomy
- Arteries
- head and neck
- arms
- chest
- abdomen
- legs
- Veins
- head and neck
- arms
- chest
- abdomen and pelvis
- legs
- Development
- Cells
- Physiology
|
|
Disease |
- Congenital
- Neoplasms and cancer
- Lymphatic vessels
- Injury
- Vasculitis
- Other
- Symptoms and signs
|
|
Treatment |
- Procedures
- Drugs
- beta blockers
- channel blockers
- diuretics
- nonsympatholytic vasodilatory antihypertensives
- peripheral vasodilators
- renin–angiotensin system
- sympatholytic antihypertensives
- vasoprotectives
|
|
|
English Journal
- Quantification of 21 antihypertensive drugs in serum using UHPLC-MS/MS.
- Gundersen POM1, Helland A2, Spigset O3, Hegstad S4.
- Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.J Chromatogr B Analyt Technol Biomed Life Sci.2018 Jul 1;1089:84-93. doi: 10.1016/j.jchromb.2018.04.038. Epub 2018 Apr 28.
- PMID 29783197
- Effect of vinylpyrrolidone polymers on the solubility and supersaturation of drugs; a study using the Cheqsol method.
- Fornells E1, Fuguet E2, Mañé M1, Ruiz R3, Box K4, Bosch E5, Ràfols C6.
- European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.Eur J Pharm Sci.2018 May 30;117:227-235. doi: 10.1016/j.ejps.2018.02.025. Epub 2018 Feb 23.
- PMID 29481859
- Spontaneous and α-adrenoceptor-induced contractility in human collecting lymphatic vessels require chloride.
- Mohanakumar S1,2,3, Majgaard J1,3, Telinius N1,3, Katballe N2,3, Pahle E4, Hjortdal V2,3, Boedtkjer D1,2,3.
- American journal of physiology. Heart and circulatory physiology.Am J Physiol Heart Circ Physiol.2018 Aug 1;315(2):H389-H401. doi: 10.1152/ajpheart.00551.2017. Epub 2018 Apr 6.
- PMID 29631375
Japanese Journal
- Impact of antihypertensive treatment on quality of life : comparison between bisoprolol and bendrofluazide
- Relation between dose of bendrofluazide, anti-hypertensive effect, and adverse biochemical effects
Related Pictures